Detalhe da pesquisa
1.
Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation.
PLoS Pathog
; 14(7): e1007208, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30052682
2.
Neoantigen landscape in metastatic nasopharyngeal carcinoma.
Theranostics
; 11(13): 6427-6444, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995666
3.
Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies.
Theranostics
; 9(4): 1115-1124, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867819
4.
Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
Cancer Res
; 79(23): 5930-5943, 2019 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31484669
5.
Correction: TNFRSF19 Inhibits TGFß Signaling through Interaction with TGFß Receptor Type 1 to Promote Tumorigenesis.
Cancer Res
; 83(7): 1158, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37014045
6.
TNFRSF19 Inhibits TGFß Signaling through Interaction with TGFß Receptor Type I to Promote Tumorigenesis.
Cancer Res
; 78(13): 3469-3483, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29735548
7.
BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc.
Cell Death Dis
; 9(7): 761, 2018 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29988031
8.
Vasculogenic mimicry formation in EBV-associated epithelial malignancies.
Nat Commun
; 9(1): 5009, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30479336
9.
A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Cancer Lett
; 381(1): 14-22, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27424523